Novel flexible vesicles based topical formulation of levocetirizine: In vivo evaluation using oxazolone-induced atopic dermatitis in murine model

Journal of Liposome Research

Volumn 24, Issue 3, 2014, Pages 249-257

  Goindi, Shishu ^a   Kumar, Gautam ^a   Kaur, Amanpreet ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Antihistaminic; Atopic dermatitis; Flexible vesicles; Levocetirizine; Topical delivery

Indexed keywords

CARBOPOL 940; CHOLESTEROL; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; LEVOCETIRIZINE; LIPOSOME; OCTADECYLAMINE; OXAZOLONE; PHOSPHATIDYLCHOLINE; SORBITAN OLEATE; CETIRIZINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CHEMICALLY INDUCED DISORDER; CONTROLLED STUDY; CREAM; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG RETENTION; DRUG SAFETY; EOSINOPHIL; EOSINOPHIL COUNT; ERYTHEMA; EX VIVO STUDY; FEMALE; FILM; GEL; HISTOPATHOLOGY; HYDRATION; HYDROCOLLOID; IN VIVO STUDY; LIPOSOMAL DELIVERY; MAST CELL; MORPHOLOGICAL TRAIT; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; SCRATCHING; SKIN PERMEABILITY; SKIN SENSITIVITY; SKIN SURFACE; STRATUM CORNEUM; SURFACE CHARGE; ZETA POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DERMATITIS, ATOPIC; ELASTICITY; INTRADERMAL DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; METABOLISM; PATHOLOGY; SKIN;

ADMINISTRATION, CUTANEOUS; ANIMALS; CETIRIZINE; CHEMISTRY, PHARMACEUTICAL; DERMATITIS, ATOPIC; ELASTICITY; FEMALE; LIPOSOMES; MICE, INBRED BALB C; OXAZOLONE; SKIN;

EID: 84906282859     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2014.899365     Document Type: Article

References (31)

1. Agarwal R, Saraswat A, Katare OP, Kumar B. (2002). A novel liposomal formulation of dithranol in psoriasis: preliminary results. J Dermatol 29:529-32.
2. Aggarwal N, Goindi S. (2012). Preparation and evaluation of antifungal efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea pig model of Microsporum canis- Dermatophytosis. Int J Pharm 437:277-87.
3. Bae S, Tanaka Y, Ogawa F, et al. (2002). Inhibitory effect of cetirizine on histamine-induced eotaxin production in normal human fibroblasts. Curr Therapeut Res 63:128-40.
4. Barry BW. (1983). Percutaneous absorption. New York: Marcel Dekker.
5. Bernard E, Dubois JL, Wepierre J. (1995). Percutaneous absorption of new antiandrogen included in liposomes or in solution. Int J Pharm 126:235-43.
6. Campoli-Richards DMB, Micaela M-T, Fitton A. (1990). Cetirizine: a review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria. Drugs 40:762-81.
7. Cevc G. (2003). Transdermal drug delivery of insulin with ultradeformable carriers. Clin Pharmacokinetics 42:461-74.
8. Chuang GCC, Yeh A-I. (2006). Rheological characteristics and texture attributes of glutinous rice cakes (mochi). J Food Engineering 74: 314-23.
9. Dubey V, Mishra D, Jain NK. (2007). Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm 67:398-405.
10. El Maghraby GMM, Williams AC, Barry BW. (2000). Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm 196:63-74.
11. Elias JA, Lee CG, Zheng T, et al. (2003). New insights into the pathogenesis of asthma. J Clin Invest 111:291-7.
12. Elias PM, Steinhoff M. (2008). "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 128:1067-70.
13. Elias PM, Williams ML, Crumrine D, Schmuth M. (2010). Inherited disorders of corneocyte proteins. Curr Probl Dermatol 39: 98-131.
14. El Maghraby GMM, Williams AC, Barry BW. (2001). Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in vitro. J Pharm Pharmacol 53:1069-77.
15. Fujisawa T, Terada A, Atsuta J, et al. (1997). IL-5 as strong secretagogue for human eosinophils. Int Arch Allergy Immunol 114: 81-3.
16. Grewe M, Gyufko K, Scho?pf E, Krutmann J. (2000). Lesional expression of interferon-gamma in atopic eczema. Lancet 343:25-6.
17. Hasala H, Janka-Junttila M, Moilanen E, Kankaanranta H. (2007). Levocetirizine and cytokine production and apoptosis of human eosinophils. Allergy Asthma Proc 28:582-9.
18. Jain S, Jain P, Jain NK, Umamaheshwari RB. (2003). Transfersomes-a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm 29:1013-26.
19. Kaminishi K, Soma Y, Kawa Y, Mizoguchi M. (2002). Flow cytometric analysis of IL-4, IL-13 and IFN-gamma expression in peripheral blood mononuclear cells and detection of circulating IL-13 in patients with atopic dermatitis provide evidence for the involvement of type 2 cytokines in the disease. J Dermatol Sci 29: 19-25.
20. Mahmoud F, Arifhodzic N, Al-awadhi R, Haines D. (2009). Intracellular cytokine production in children with atopic dermatitis effect of levocetirizine treatment. Pedijatrija danas 5:162-71.
21. Man M, Hatano Y, Lee SH, et al. (2008). Characterization of a hapteninduced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol 128: 79-86.
22. Merukar SS, Mhaskar PS, Bhavaskar SR, et al. (2009). Simultaneous spectrophotometric methods for estimation of levocetirizine and pseudoephedrine in pharmaceutical tablet dosage form. J Pharm Sci Res 1:38-42.
23. Mueller TD, Zhang JL, Sebald W, Duschl A. (2002). Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochim Biophys Acta 1592:237-50.
24. Nolte T, Khorasani MZ, Safarov O, et al. (2013). Induction of oxazolonemediated features of atopic dermatitis in NOD-scid IL2Rgnull mice engrafted with human peripheral blood mononuclear cells. Dis Model Mech 6:125-34.
25. Obara W, Kawa Y, Ra C, et al. (2002). T cells and mast cells as a major source of interleukin-13 in atopic dermatitis. Dermatology 205: 11-17.
26. Oshio T, Sasaki Y, Funakoshi-Tago M, et al. (2009). Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment. Int Immunopharmacol 9:403-11.
27. Ott NL, Gleich GJ, Peterson EA, et al. (1994). Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE mediated late-phase reaction. J Allergy Clin Immunol 94:120-8.
28. Panchognula R. (1997). Transdermal delivery of drugs. Ind J Pharmacol 140:140-56.
29. Prabhu P, Malli R, Koland M, et al. (2011). Formulation and evaluation of fast dissolving films of levocetirizine di hydrochloride. Int J Pharm Invest 1:99-104.
30. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. (2000). Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65:403-18.
31. Wollenberg A, Kraft S, Oppel T, Bieber T. (2000). Atopic dermatitis: pathogenetic mechanisms. Clin Exp Dermatol 25:530-4.